EMBO Reports is described as a well-established journal with a good reputation and rigorous peer review process, primarily focusing on articles related to molecular biology. Cell Reports is also an open access journal with a good reputation.

(0) Thank | Adelaide Lawson

Which journal has a better reputation, Embo reports or Cell reports?

(0) Thank | 努力啊大路喧

Returning to Zone One

(0) Thank | 四风丽苹

How long did it take for you to receive the successful submission email?

(0) Thank | Alexander Browne

Review Speed: 3.0 | Submission Acceptance Rate: 25.0
Experience Sharing: Lucky to have one article accepted. Although the Impact Factor is not high, the quality of the journal is very good and the review process is very strict

(0) Thank | 桃花高驰

The initial review process will take about 50 days, within two months

(0) Thank | 长安丝琦

The authoritative journal in the field of molecular biology has strict review process. The review team consists of industry experts, and the review comments are very professional and of high quality. Articles with a high workload are worth a try

(60) Thank | Jackson S2023

Within one month

(0) Thank | 蒙德明知

The first trial will be completed in about a month

(0) Thank | 风见婉君

Fast delivery, within one week

(0) Thank | 风见婉君

Within a week

(0) Thank | 四风丽苹

Okay, thank you

(0) Thank | 月河樱潼

Recently, there are teachers who have submitted to this journal. How long does the initial review usually take?

(0) Thank | 月河樱潼

I really don't understand why this journal, which is quite good, has been categorized as level two

(0) Thank | 蒙德明知

Old magazines, the reputation is still good. The review process is also very rigorous, unlike some inferior journals. What is puzzling is that a small CDD edited by a Chinese expert has become a first-tier journal, while this one has been kicked out of the first-tier. I can't understand it.

(36) Thank | keyanxiaolj

I don't know if the leaders of the country are aware of how excessively the Chinese Academy of Sciences uses the baton in its division. Supporting domestic journals is a good thing, but it shouldn't be done at the expense of pulling up seedlings to help them grow. It disregards the life and death of personnel without qualifications. This is also the way it is for the scientific research big shots. They randomly publish and it becomes a first-tier journal. Thumbs up!

(0) Thank | 指挥棒

Typical of making a big deal out of trivial matters, replacing classic journals with domestic ones. But can the domestic journals be obtained by researchers with no qualifications? They are just taking advantage of leaders' lack of understanding in research and messing around, truly amazing!

(0) Thank | 指挥棒

?, kick out of the first division, kick out of the top, IJMS and other water journals are all top, is this how you use a baton?

(32) Thank | 指挥棒

Currently, there is a paper in the second round of review, which has been resubmitted to a different journal after being rejected by a top-tier journal. The first round of review provided more than 20 comments, which were exceptionally strict.

Does the classification system of the Chinese Academy of Sciences aim to eliminate good papers in favor of inferior ones?

(28) Thank | 方建

Research focus: Experience sharing of stem cells: Haha, everyone don't submit anymore, as the latest version of the Chinese Academy of Sciences partition in 2022, this journal has been removed from the first tier. The authority is powerful!

(0) Thank | 四风丽苹

Review speed: 2.0 | Submission hit rate: 25.0 Emphasized research direction: Tumor sharing experience: EMBO reports The current editor-in-chief is Professor Bernd Pulverer, who previously served as the editor of Nature Cell Biology. The magazine tends to publish articles with conceptual advances, with an average time from submission to acceptance of around 8 months

(0) Thank | 辉夜一莹

EMBO Publishing House, the second-in-command, was established in 2000. Cell reports, under the umbrella of CELL, should be imitating the publishing concept of this magazine, with an extremely similar style. However, EMBO reports are more rigorous. Everyone can try submitting their articles, and if you get accepted after external review, you will have a profound experience. It mainly accepts articles related to molecular biology. The magazine is very good, but there are very few Chinese submissions. It is mainly favored by some researchers from Chinese institutes.

(10) Thank | slientwo

Are you going back for rework? How long has the rework been going on? What is the status like?

(0) Thank | 弘致小姐姐

How can I not receive the decision letter, the editor does not reply, what should I do

(0) Thank | 平原如彤

How long did it take for you to receive the email after May 11th?

(0) Thank | 墟散伟博